Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive

NCT02699645 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT02699645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02699645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Completed
Start date
September 28, 2017
Completion date
August 27, 2025
Enrollment
1,671 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, intracerebral haemorrhage (ich)